Clinical Research Strategies, Inc.

Houston, Texas 77090

2 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Diseases, End Stage Kidney Disease, Type 2 Diabetes Mellitus

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease — Recruiting now